Experimental diets dictate the metabolic benefits of probiotics in obesity

Growing evidence supports the use of probiotics to prevent or mitigate obesity-related dysmetabolism and non-alcoholic fatty liver disease (NAFLD). However, frequent reports of responders versus non-responders to probiotic treatment warrant a better understanding of key modifiers of host–microbe int...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, Ida Søgaard, Choi, Béatrice S.-Y., Föh, Bandik, Kristensen, Nanna Ny, Ouellette, Adia, Haller, Rune Falkenberg, Olsen, Peter Bjarke, Saulnier, Delphine, Sina, Christian, Jensen, Benjamin A. H., Marette, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038044/
https://www.ncbi.nlm.nih.gov/pubmed/36945120
http://dx.doi.org/10.1080/19490976.2023.2192547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038044/
https://www.ncbi.nlm.nih.gov/pubmed/36945120
http://dx.doi.org/10.1080/19490976.2023.2192547

Ejemplares similares